Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Primovist for MRI of Focal Liver Lesions in Chinese Patients
NCT00526188Phase 3Completed
- Sponsor
- Bayer
- Start
- Aug 2007
- Primary completion
- Aug 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of gadoxetate disodium in focal liver lesions (FLLs), sponsored by Bayer. Started Aug 2007; status: completed.
02
Drugs
gadoxetate disodium
03
Conditions
focal liver lesions (FLLs)
Beyond the preview
Go deeper on NCT00526188.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00526188.